Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Urology
|
November 17, 2001
Molecular prediction of progression in patients with conservatively managed prostate cancer
I G McIntyre, R B Clarke, E Anderson, et al.
Journal of Enzyme Inhibition
|
January 1, 1991
Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease
F S Steven, M M Griffin, L A Williams, et al.
British Journal of Cancer
|
January 22, 2004
An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines
V K Sangar, R Cowan, G P Margison, et al.
Postgraduate Medical Journal
|
January 11, 2005
National review of urology outpatient practice in the UK
P E Gilmore, D C Shackley, N W Clarke, et al.
British Journal of Cancer
|
December 22, 2004
Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines
S B Maddineni, V K Sangar, J H Hendry, et al.
Oncogene
|
January 18, 2022
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
A Cannistraci, P Hascoet, A Ali, et al.
The Prostate
|
March 11, 1998
Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma
S H Lang, N W Clarke, N J George, et al.
Histopathology
|
May 1, 1997
Primary peripheral primitive neuroectodermal tumour of urinary bladder
S S Banerjee, B P Eyden, R J McVey, et al.
British Journal of Cancer
|
November 6, 2008
FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer
M J Baker, E Gazi, M D Brown, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Invasive phenotype of primary human prostatic epithelial cells
L J Scott, N W Clarke, M S Sharrard, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Urology
|
November 17, 2001
Molecular prediction of progression in patients with conservatively managed prostate cancer
I G McIntyre, R B Clarke, E Anderson, et al.
Journal of Enzyme Inhibition
|
January 1, 1991
Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease
F S Steven, M M Griffin, L A Williams, et al.
British Journal of Cancer
|
January 22, 2004
An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines
V K Sangar, R Cowan, G P Margison, et al.
Postgraduate Medical Journal
|
January 11, 2005
National review of urology outpatient practice in the UK
P E Gilmore, D C Shackley, N W Clarke, et al.
British Journal of Cancer
|
December 22, 2004
Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines
S B Maddineni, V K Sangar, J H Hendry, et al.
Oncogene
|
January 18, 2022
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
A Cannistraci, P Hascoet, A Ali, et al.
The Prostate
|
March 11, 1998
Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma
S H Lang, N W Clarke, N J George, et al.
Histopathology
|
May 1, 1997
Primary peripheral primitive neuroectodermal tumour of urinary bladder
S S Banerjee, B P Eyden, R J McVey, et al.
British Journal of Cancer
|
November 6, 2008
FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer
M J Baker, E Gazi, M D Brown, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Invasive phenotype of primary human prostatic epithelial cells
L J Scott, N W Clarke, M S Sharrard, et al.
Page
of 9